Search

Displaying results 2441 - 2450 of 2743 in total
  1. Drug

    Tunodafil

    go.drugbank.com/drugs/DB21576
    Investigational

    The usage of the INN stem '-afil' in the name indicates that Tunodafil is a inhibitor of phosphodiesterase PDE5 with vasodilator action.

  2. Drug

    Resomelagon

    go.drugbank.com/drugs/DB21579
    Investigational

    The usage of the INN stem '-melagon' in the name indicates that Resomelagon is a non-peptidic melanocortin receptor agonist.

  3. Drug

    Basroparib

    go.drugbank.com/drugs/DB21582
    Investigational

    The usage of the INN stem '-parib' in the name indicates that Basroparib is a poly-ADP-Ribose polymerase inhibitor.

  4. Drug

    Gridegalutamide

    go.drugbank.com/drugs/DB21593
    Investigational

    The usage of the INN stem '-lutamide' in the name indicates that Gridegalutamide is a non-steroid antiandrogen.

  5. Drug

    Docirbrutinib

    go.drugbank.com/drugs/DB21606
    Investigational

    The usage of the INN stem '-brutinib' in the name indicates that Docirbrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  6. Drug

    Tamuzimod

    go.drugbank.com/drugs/DB21621
    Investigational

    The usage of the INN stem '-imod' in the name indicates that Tamuzimod is a immunomodulator, both stimulant/suppressive and stimulant.

  7. Drug

    Lomedeucitinib

    go.drugbank.com/drugs/DB21649
    Investigational

    The usage of the INN stem '-citinib' in the name indicates that Lomedeucitinib is a Janus kinase inhibitor.

  8. Drug

    Bimokalner

    go.drugbank.com/drugs/DB21717
    Investigational

    The usage of the INN stem '-kalner' in the name indicates that Bimokalner is a opener of calcium-activated (maxi-K) K+-channel.

  9. Drug

    Ocadusertib

    go.drugbank.com/drugs/DB21732
    Investigational

    The usage of the INN stem '-sertib' in the name indicates that Ocadusertib is a serine/threonine kinase inhibitor.

  10. Drug

    Darifenacin

    go.drugbank.com/drugs/DB00496
    ApprovedInvestigational

    Darifenacin (Enablex®, Novartis) is a medication used to treat urinary incontinence. Darifenacin blocks M3 muscarinic acetylcholine receptors, which mediate bladder muscle contractions. This block reduces the urgency to urinate and so it...

    Categories: Genito Urinary System and Sex Hormones